{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:08:25Z","timestamp":1791263305929,"version":"4.1.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/nrcardio.2016.118","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T10:45:47Z","timestamp":1470307547000},"page":"575-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation"],"prefix":"10.1038","volume":"13","author":[{"given":"Stanley","family":"Nattel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"BFnrcardio2016118_CR1","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","volume":"114","author":"J Andrade","year":"2014","unstructured":"Andrade, J., Khairy, P., Dobrev, D. & Nattel, S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 114, 1453\u20131468 (2014).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2217\/fca.12.78","volume":"9","author":"J Heijman","year":"2013","unstructured":"Heijman, J., Voigt, N. & Dobrev, D. New directions in antiarrhythmic drug therapy for atrial fibrillation. Future Cardiol. 9, 71\u201388 (2013).","journal-title":"Future Cardiol."},{"key":"BFnrcardio2016118_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/S0140-6736(10)60096-7","volume":"375","author":"D Dobrev","year":"2010","unstructured":"Dobrev, D. & Nattel, S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 375, 1212\u20131223 (2010).","journal-title":"Lancet"},{"key":"BFnrcardio2016118_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/europace\/eus027","volume":"14","author":"H Calkins","year":"2012","unstructured":"Calkins, H.  et al. 2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14, 528\u2013606 (2012).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR5","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1172\/JCI46315","volume":"121","author":"R Wakili","year":"2011","unstructured":"Wakili, R., Voigt, N., K\u00e4\u00e4b, S., Dobrev, D. & Nattel, S. Recent advances in the molecular pathophysiology of atrial fibrillation. J. Clin. Invest. 121, 2955\u20132968 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2016118_CR6","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","volume":"114","author":"J Heijman","year":"2014","unstructured":"Heijman, J., Voigt, N., Nattel, S. & Dobrev, D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ. Res. 114, 1483\u20131499 (2014).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/joim.12492","volume":"279","author":"U Schotten","year":"2016","unstructured":"Schotten, U., Dobrev, D., Platonov, P. G., Kottkamp, H. & Hindricks, G. Current controversies in determining the main mechanisms of atrial fibrillation. J. Intern. Med. 279, 428\u2013438 (2016).","journal-title":"J. Intern. Med."},{"key":"BFnrcardio2016118_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel, S., Burstein, B. & Dobrev, D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 1, 62\u201373 (2008).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2016118_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/eurheartj\/ehu028","volume":"35","author":"S Nattel","year":"2014","unstructured":"Nattel, S.  et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur. Heart J. 35, 1448\u20131456 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2016118_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jacep.2015.12.014","volume":"2","author":"HS Lim","year":"2016","unstructured":"Lim, H. S.  et al. Persistent atrial fibrillation from the onset: a specific subgroup of patients with biatrial substrate involvement and poorer clinical outcome. JACC Clin. Electrophysiol. 2, 129\u2013139 (2016).","journal-title":"JACC Clin. Electrophysiol."},{"key":"BFnrcardio2016118_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/hc0902.104712","volume":"105","author":"H Oral","year":"2002","unstructured":"Oral, H.  et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 105, 1077\u20131081 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1540-8167.2006.00407.x","volume":"17","author":"S Eijsbouts","year":"2006","unstructured":"Eijsbouts, S.  et al. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat. J. Cardiovasc. Electrophysiol. 17, 648\u2013654 (2006).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.113.005421","volume":"130","author":"M Haissaguerre","year":"2014","unstructured":"Haissaguerre, M.  et al. Driver domains in persistent atrial fibrillation. Circulation 130, 530\u2013538 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.CIR.95.3.572","volume":"95","author":"P Ja\u00efs","year":"1997","unstructured":"Ja\u00efs, P.  et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95, 572\u2013576 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Ha\u00efssaguerre","year":"1998","unstructured":"Ha\u00efssaguerre, M.  et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339, 659\u2013666 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2016118_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0008-6363(02)00263-8","volume":"54","author":"P Ja\u00efs","year":"2002","unstructured":"Ja\u00efs, P.  et al. Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc. Res. 54, 337\u2013346 (2002).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0140-6736(15)60026-5","volume":"386","author":"L Macle","year":"2015","unstructured":"Macle, L.  et al. Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet 386, 672\u2013679 (2015).","journal-title":"Lancet"},{"key":"BFnrcardio2016118_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/europace\/eun016","volume":"10","author":"I Drewitz","year":"2008","unstructured":"Drewitz, I.  et al. Persistent, isolated pulmonary vein re-entry: inducibility, entrainment, and overdrive termination of a sustained tachycardia within an isolated pulmonary vein. Europace 10, 261\u2013264 (2008).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR19","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.106.633735","volume":"114","author":"F Atienza","year":"2006","unstructured":"Atienza, F.  et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation 114, 2434\u20132442 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1540-8159.2012.03395.x","volume":"35","author":"S Nattel","year":"2012","unstructured":"Nattel, S. Adenosine and atrial arrhythmias: exploring electrophysiological mechanisms in vivo. Pacing Clin. Electrophysiol. 35, 553\u2013555 (2012).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio2016118_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1540-8167.2011.02089.x","volume":"22","author":"AW Teh","year":"2011","unstructured":"Teh, A. W.  et al. Electroanatomic properties of the pulmonary veins: slowed conduction, low voltage and altered refractoriness in AF patients. J. Cardiovasc. Electrophysiol. 22, 1083\u20131091 (2011).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1540-8167.2011.02178.x","volume":"23","author":"AW Teh","year":"2012","unstructured":"Teh, A. W.  et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J. Cardiovasc. Electrophysiol. 23, 232\u2013238 (2012).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jacc.2008.11.054","volume":"53","author":"MK Stiles","year":"2009","unstructured":"Stiles, M. K.  et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the 'second factor'. J. Am. Coll. Cardiol. 53, 1182\u20131191 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR24","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1111\/j.1540-8159.2005.00020.x","volume":"28","author":"D Cozma","year":"2005","unstructured":"Cozma, D.  et al. Mechanism of atrial fibrillation: decremental conduction, fragmentation, and ectopic activity in patients with drug resistance paroxysmal atrial fibrillation and structurally normal heart. Pacing Clin. Electrophysiol. 28, S115\u2013S119 (2005).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio2016118_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijcard.2016.02.092","volume":"210","author":"H Yamabe","year":"2016","unstructured":"Yamabe, H., Kanazawa, H., Itoh, M., Kaneko, S. & Ogawa, H. Difference in the maintenance mechanism of atrial fibrillation perpetuated after pulmonary vein isolation between paroxysmal and persistent atrial fibrillation: effects of subsequent stepwise ablation. Int. J. Cardiol. 210, 109\u2013118 (2016).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio2016118_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/europace\/euj043","volume":"8","author":"A Vincenti","year":"2006","unstructured":"Vincenti, A., Brambilla, R., Fumagalli, M. G., Merola, R. & Pedretti, S. Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. Europace 8, 204\u2013210 (2006).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR27","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1161\/01.CIR.0000018443.44005.D8","volume":"105","author":"M Bettoni","year":"2002","unstructured":"Bettoni, M. & Zimmermann, M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 105, 2753\u20132759 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1540-8167.2009.01658.x","volume":"21","author":"R Rosso","year":"2010","unstructured":"Rosso, R.  et al. Vagal paroxysmal atrial fibrillation: prevalence and ablation outcome in patients without structural heart disease. J. Cardiovasc. Electrophysiol. 21, 489\u2013493 (2010).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/euhj.2000.2517","volume":"22","author":"JE Waktare","year":"2001","unstructured":"Waktare, J. E.  et al. The role of atrial ectopics in initiating paroxysmal atrial fibrillation. Eur. Heart J. 22, 333\u2013339 (2001).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2016118_CR30","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/cvr\/cvr329","volume":"93","author":"T Hattori","year":"2012","unstructured":"Hattori, T.  et al. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc. Res. 93, 666\u2013673 (2012).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2350-13-24","volume":"13","author":"MS Olesen","year":"2012","unstructured":"Olesen, M. S.  et al. Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med. Genet. 13, 24 (2012).","journal-title":"BMC Med. Genet."},{"key":"BFnrcardio2016118_CR32","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1073\/pnas.1218154110","volume":"110","author":"M Deo","year":"2013","unstructured":"Deo, M.  et al. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia. Proc. Natl Acad. Sci. USA 110, 4291\u20134296 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2016118_CR33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1540-8167.2005.40621.x","volume":"16","author":"K Hong","year":"2005","unstructured":"Hong, K., Bjerregaard, P., Gussak, I. & Brugada, R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J. Cardiovasc. Electrophysiol. 16, 394\u2013396 (2005).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cell.2008.10.022","volume":"135","author":"X Zhang","year":"2008","unstructured":"Zhang, X.  et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 135, 1017\u20131027 (2008).","journal-title":"Cell"},{"key":"BFnrcardio2016118_CR35","doi-asserted-by":"publisher","first-page":"870.e7","DOI":"10.1016\/j.cjca.2011.02.003","volume":"27","author":"P Kazemian","year":"2011","unstructured":"Kazemian, P., Gollob, M. H., Pantano, A. & Oudit, G. Y. A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by \u03b2-blocker therapy. Can. J. Cardiol. 27, 870.e7\u201310 (2011).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio2016118_CR36","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.jacc.2013.06.052","volume":"62","author":"DL Beavers","year":"2013","unstructured":"Beavers, D. L.  et al. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J. Am. Coll. Cardiol. 62, 2010\u20132019 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCEP.114.001973","volume":"7","author":"DY Chiang","year":"2014","unstructured":"Chiang, D. Y.  et al. Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release. Circ. Arrhythm. Electrophysiol. 7, 1214\u20131222 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2016118_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2350-7-70","volume":"7","author":"PT Ellinor","year":"2006","unstructured":"Ellinor, P. T., Petrov-Kondratov, V. I., Zakharova, E., Nam, E. G. & MacRae, C. A. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med. Genet. 7, 70 (2006).","journal-title":"BMC Med. Genet."},{"key":"BFnrcardio2016118_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cjca.2013.07.797","volume":"29","author":"S Nattel","year":"2013","unstructured":"Nattel, S. Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms. Can. J. Cardiol. 29, 1147\u20131149 (2013).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio2016118_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/j.1445-5994.2011.02600.x","volume":"42","author":"S Lindberg","year":"2012","unstructured":"Lindberg, S., Hansen, S. & Nielsen, T. Spontaneous conversion of first onset atrial fibrillation. Intern. Med. J. 42, 1195\u20131199 (2012).","journal-title":"Intern. Med. J."},{"key":"BFnrcardio2016118_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0008-6363(02)00490-X","volume":"55","author":"S Verheule","year":"2002","unstructured":"Verheule, S.  et al. Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc. Res. 55, 727\u2013738 (2002).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR42","first-page":"H1735","volume":"269","author":"EI Watanabe","year":"1995","unstructured":"Watanabe, E. I.  et al. Modulation of pacemaker activity of sinoatrial node cells by electrical load imposed by an atrial cell model. Am. J. Physiol. 269, H1735\u2013H1742 (1995).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio2016118_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1113\/jphysiol.2003.046417","volume":"551","author":"JR Ehrlich","year":"2003","unstructured":"Ehrlich, J. R.  et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J. Physiol. 551, 801\u2013813 (2003).","journal-title":"J. Physiol."},{"key":"BFnrcardio2016118_CR44","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/01.CIR.0000016062.80020.11","volume":"105","author":"M Hocini","year":"2002","unstructured":"Hocini, M.  et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation 105, 2442\u20132448 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cardiores.2007.05.008","volume":"75","author":"N Ozgen","year":"2007","unstructured":"Ozgen, N.  et al. Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. Cardiovasc. Res. 75, 758\u2013769 (2007).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR46","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.113.003019","volume":"129","author":"X-Y Qi","year":"2014","unstructured":"Qi, X.-Y.  et al. Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog. Circulation 129, 430\u2013440 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR47","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1529\/biophysj.105.060459","volume":"88","author":"SV Pandit","year":"2005","unstructured":"Pandit, S. V.  et al. Ionic determinants of functional reentry in a 2D model of human atrial cells during simulated chronic atrial fibrillation. Biophys. J. 88, 3806\u20133821 (2005).","journal-title":"Biophys. J."},{"key":"BFnrcardio2016118_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCULATIONAHA.113.006641","volume":"129","author":"N Voigt","year":"2014","unstructured":"Voigt, N.  et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129, 145\u2013156 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR49","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.ijcard.2013.01.239","volume":"168","author":"F Zhao","year":"2013","unstructured":"Zhao, F.  et al. Calreticulin overexpression correlates with integrin-\u03b15 and transforming growth factor-\u03b21 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation. Int. J. Cardiol. 168, 2177\u20132185 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio2016118_CR50","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","volume":"125","author":"N Voigt","year":"2012","unstructured":"Voigt, N.  et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125, 2059\u20132070 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jacc.2014.10.042","volume":"65","author":"DY Chiang","year":"2015","unstructured":"Chiang, D. Y.  et al. Alterations in the interactome of serine\/threonine protein phosphatase type-1 in atrial fibrillation patients. J. Am. Coll. Cardiol. 65, 163\u2013173 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0008-6363(99)00045-0","volume":"42","author":"BJ Brundel","year":"1999","unstructured":"Brundel, B. J.  et al. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc. Res. 42, 443\u2013454 (1999).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCULATIONAHA.114.013708","volume":"131","author":"SA Smith","year":"2015","unstructured":"Smith, S. A.  et al. Dysfunction in the \u03b2II spectrin-dependent cytoskeleton underlies human arrhythmia. Circulation 131, 695\u2013708 (2015).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR54","doi-asserted-by":"publisher","first-page":"H1583","DOI":"10.1152\/ajpheart.00875.2015","volume":"310","author":"S Smith","year":"2016","unstructured":"Smith, S.  et al. Dysfunction of the \u03b2II spectrin-based pathway in human heart failure. Am. J. Physiol. Heart Circ. Physiol. 310, H1583\u2013H1591 (2016).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2016118_CR55","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1161\/CIRCULATIONAHA.111.023986","volume":"124","author":"SR Cunha","year":"2011","unstructured":"Cunha, S. R.  et al. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. Circulation 124, 1212\u20131222 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.114.012657","volume":"132","author":"C Schmidt","year":"2015","unstructured":"Schmidt, C.  et al. Upregulation of K2P3.1 K+ current causes action potential shortening in patients with chronic atrial fibrillation. Circulation 132, 82\u201392 (2015).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.hrthm.2015.10.003","volume":"13","author":"J Ford","year":"2016","unstructured":"Ford, J.  et al. The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation. Heart Rhythm 13, 555\u2013564 (2016).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2016118_CR58","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCEP.110.954636","volume":"3","author":"N Voigt","year":"2010","unstructured":"Voigt, N.  et al. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3, 472\u2013480 (2010).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2016118_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00395-015-0505-6","volume":"110","author":"E Glasscock","year":"2015","unstructured":"Glasscock, E.  et al. Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation. Bas. Res. Cardiol. 110, 505 (2015).","journal-title":"Bas. Res. Cardiol."},{"issue":"Suppl. 1","key":"BFnrcardio2016118_CR60","first-page":"183","volume":"35","author":"X Zhou","year":"2014","unstructured":"Zhou, X.  et al. Increased trafficking of Ca2+-activated K+ channels to plasma membrane modulates action potential duration in human paroxysmal atrial fibrillation. Eur. Heart J. 35 (Suppl. 1), 183 [abstract 1041] (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2016118_CR61","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0735-1097(00)01195-5","volume":"37","author":"BJ Brundel","year":"2001","unstructured":"Brundel, B. J.  et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J. Am. Coll. Cardiol. 37, 926\u2013932 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR62","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/01.CIR.103.5.684","volume":"103","author":"BJ Brundel","year":"2001","unstructured":"Brundel, B. J.  et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103, 684\u2013690 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yjmcc.2013.03.011","volume":"61","author":"N Voigt","year":"2013","unstructured":"Voigt, N.  et al. Impaired Na+-dependent regulation of acetylcholine-activated inward-rectifier K+ current modulates action potential rate dependence in patients with chronic atrial fibrillation. J. Mol. Cell. Cardiol. 61, 142\u2013152 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2016118_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijcard.2015.01.075","volume":"184","author":"DY Chiang","year":"2015","unstructured":"Chiang, D. Y.  et al. Identification of microRNA-mRNA dysregulations in paroxysmal atrial fibrillation. Int. J. Cardiol. 184, 190\u2013197 (2015).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio2016118_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jacc.2015.04.056","volume":"66","author":"M Harada","year":"2015","unstructured":"Harada, M.  et al. Atrial fibrillation activates AMP-dependent protein kinase and its regulation of cellular calcium handling: potential role in metabolic adaptation and prevention of progression. J. Am. Coll. Cardiol. 66, 47\u201358 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR66","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.113.006611","volume":"129","author":"N Li","year":"2014","unstructured":"Li, N.  et al. Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation 129, 1276\u20131285 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.yjmcc.2014.08.021","volume":"76","author":"J Gemel","year":"2014","unstructured":"Gemel, J.  et al. Connexin40 abnormalities and atrial fibrillation in the human heart. J. Mol. Cell. Cardiol. 76, 159\u2013168 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2016118_CR68","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0008-6363(02)00289-4","volume":"54","author":"BJJM Brundel","year":"2002","unstructured":"Brundel, B. J. J. M.  et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc. Res. 54, 380\u2013389 (2002).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR69","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.yjmcc.2008.08.012","volume":"45","author":"L Ke","year":"2008","unstructured":"Ke, L.  et al. Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation. J. Mol. Cell. Cardiol. 45, 685\u2013693 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2016118_CR70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","volume":"129","author":"D Zhang","year":"2014","unstructured":"Zhang, D.  et al. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of \u03b1-tubulin proteostasis in experimental and human atrial fibrillation. Circulation 129, 346\u2013358 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR71","doi-asserted-by":"publisher","first-page":"28063","DOI":"10.1074\/jbc.M704893200","volume":"282","author":"CA Carnes","year":"2007","unstructured":"Carnes, C. A.  et al. Atrial glutathione content, calcium current, and contractility. J. Biol. Chem. 282, 28063\u201328073 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio2016118_CR72","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.yjmcc.2006.06.068","volume":"41","author":"BJJM Brundel","year":"2006","unstructured":"Brundel, B. J. J. M.  et al. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. J. Mol. Cell. Cardiol. 41, 555\u2013562 (2006).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2016118_CR73","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1161\/01.CIR.101.23.2678","volume":"101","author":"A Goette","year":"2000","unstructured":"Goette, A.  et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 101, 2678\u20132681 (2000).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR74","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/clc.20713","volume":"33","author":"H Xiao","year":"2010","unstructured":"Xiao, H., Lei, H., Qin, S., Ma, K. & Wang, X. TGF-\u03b21 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Clin. Cardiol. 33, 149\u2013156 (2010).","journal-title":"Clin. Cardiol."},{"key":"BFnrcardio2016118_CR75","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1046\/j.1540-8167.2001.00737.x","volume":"12","author":"BJ Brundel","year":"2001","unstructured":"Brundel, B. J.  et al. Endothelin system in human persistent and paroxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 12, 737\u2013742 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR76","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","volume":"35","author":"A Goette","year":"2000","unstructured":"Goette, A.  et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J. Am. Coll. Cardiol. 35, 1669\u20131677 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR77","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jacc.2003.08.060","volume":"43","author":"Y Nakano","year":"2004","unstructured":"Nakano, Y.  et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J. Am. Coll. Cardiol. 43, 818\u2013825 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR78","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.peptides.2010.04.019","volume":"31","author":"H Cao","year":"2010","unstructured":"Cao, H.  et al. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation. Peptides 31, 1531\u20131539 (2010).","journal-title":"Peptides"},{"key":"BFnrcardio2016118_CR79","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.jacc.2011.05.061","volume":"58","author":"PG Platonov","year":"2011","unstructured":"Platonov, P. G., Mitrofanova, L. B., Orshanskaya, V. & Ho, S. Y. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J. Am. Coll. Cardiol. 58, 2225\u20132232 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR80","doi-asserted-by":"publisher","unstructured":"Haemers, P.  et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur. Heart J. \n                    http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehv625\n                    \n                   (2015).","DOI":"10.1093\/eurheartj\/ehv625"},{"key":"BFnrcardio2016118_CR81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/europace\/eup328","volume":"12","author":"K Nishida","year":"2010","unstructured":"Nishida, K., Michael, G., Dobrev, D. & Nattel, S. Animal models for atrial fibrillation: clinical insights and scientific opportunities. Europace 12, 160\u2013172 (2010).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR82","first-page":"296","volume":"3","author":"G Riley","year":"2012","unstructured":"Riley, G., Syeda, F., Kirchhof, P. & Fabritz, L. An introduction to murine models of atrial fibrillation. Front. Physiol. 3, 296 (2012).","journal-title":"Front. Physiol."},{"key":"BFnrcardio2016118_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pcad.2005.06.002","volume":"48","author":"S Nattel","year":"2005","unstructured":"Nattel, S., Shiroshita-Takeshita, A., Brundel, B. J. J. M. & Rivard, L. Mechanisms of atrial fibrillation: lessons from animal models. Prog. Cardiovasc. Dis. 48, 9\u201328 (2005).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"BFnrcardio2016118_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccl.2008.09.005","volume":"27","author":"JE Finet","year":"2009","unstructured":"Finet, J. E., Rosenbaum, D. S. & Donahue, J. K. Information learned from animal models of atrial fibrillation. Cardiol. Clin. 27, 45\u201354 (2009).","journal-title":"Cardiol. Clin."},{"key":"BFnrcardio2016118_CR85","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.113.004742","volume":"129","author":"RP Martins","year":"2014","unstructured":"Martins, R. P.  et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation 129, 1472\u20131482 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR86","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1074\/jbc.M407864200","volume":"280","author":"FU M\u00fcller","year":"2005","unstructured":"M\u00fcller, F. U.  et al. Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J. Biol. Chem. 280, 6906\u20136914 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio2016118_CR87","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijcard.2011.10.057","volume":"166","author":"P Kirchhof","year":"2013","unstructured":"Kirchhof, P.  et al. Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int. J. Cardiol. 166, 366\u2013374 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio2016118_CR88","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/eurheartj\/eht452","volume":"36","author":"AV Glukhov","year":"2015","unstructured":"Glukhov, A. V.  et al. Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1. Eur. Heart J. 36, 686\u2013697 (2015).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2016118_CR89","first-page":"3420","volume":"119","author":"MD Levin","year":"2009","unstructured":"Levin, M. D.  et al. Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers. J. Clin. Invest. 119, 3420\u20133436 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2016118_CR90","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1172\/JCI84669","volume":"126","author":"E Wan","year":"2016","unstructured":"Wan, E.  et al. Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice. J. Clin. Invest. 126, 112\u2013122 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2016118_CR91","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/01.RES.0000173047.42236.88","volume":"97","author":"J Temple","year":"2005","unstructured":"Temple, J.  et al. Atrial fibrillation in KCNE1-null mice. Circ. Res. 97, 62\u201369 (2005).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR92","doi-asserted-by":"publisher","first-page":"H2790","DOI":"10.1152\/ajpheart.00114.2004","volume":"287","author":"J Li","year":"2004","unstructured":"Li, J., McLerie, M. & Lopatin, A. N. Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability. Am. J. Physiol. Heart Circ. Physiol. 287, H2790\u20132802 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2016118_CR93","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.hrthm.2008.10.018","volume":"6","author":"M Hirose","year":"2009","unstructured":"Hirose, M.  et al. Diacylglycerol kinase \u03b6 inhibits G\u03b1q-induced atrial remodeling in transgenic mice. Heart Rhythm 6, 78\u201384 (2009).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2016118_CR94","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.yjmcc.2008.01.012","volume":"44","author":"C-S Hong","year":"2008","unstructured":"Hong, C.-S.  et al. Overexpression of junctate induces cardiac hypertrophy and arrhythmia via altered calcium handling. J. Mol. Cell. Cardiol. 44, 672\u2013682 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2016118_CR95","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1096\/fj.01-0908fje","volume":"16","author":"C-S Hong","year":"2002","unstructured":"Hong, C.-S.  et al. Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin. FASEB J. 16, 1310\u20131312 (2002).","journal-title":"FASEB J."},{"key":"BFnrcardio2016118_CR96","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1253\/circj.CJ-11-1301","volume":"76","author":"E-K Choi","year":"2012","unstructured":"Choi, E.-K.  et al. Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-\u03b21. Circ. J. 76, 1354\u20131362 (2012).","journal-title":"Circ. J."},{"key":"BFnrcardio2016118_CR97","doi-asserted-by":"publisher","first-page":"e001733","DOI":"10.1161\/JAHA.114.001733","volume":"4","author":"C Ozcan","year":"2015","unstructured":"Ozcan, C., Battaglia, E., Young, R. & Suzuki, G. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process. J. Am. Heart Assoc. 4, e001733 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"BFnrcardio2016118_CR98","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","volume":"165","author":"HD Xiao","year":"2004","unstructured":"Xiao, H. D.  et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am. J. Pathol. 165, 1019\u20131032 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio2016118_CR99","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","volume":"107","author":"M Arad","year":"2003","unstructured":"Arad, M.  et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107, 2850\u20132856 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR100","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.110.987248","volume":"124","author":"H Watanabe","year":"2011","unstructured":"Watanabe, H.  et al. Striking in vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation 124, 1001\u20131011 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR101","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2353\/ajpath.2009.090126","volume":"175","author":"L Pretorius","year":"2009","unstructured":"Pretorius, L.  et al. Reduced phosphoinositide 3-kinase (p110\u03b1) activation increases the susceptibility to atrial fibrillation. Am. J. Pathol. 175, 998\u20131009 (2009).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio2016118_CR102","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1161\/01.CIR.0000146902.84099.26","volume":"110","author":"H-H Chen","year":"2004","unstructured":"Chen, H.-H.  et al. Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation 110, 2980\u20132987 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR103","doi-asserted-by":"publisher","first-page":"H1561","DOI":"10.1152\/ajpheart.00285.2006","volume":"292","author":"SE Sawaya","year":"2007","unstructured":"Sawaya, S. E.  et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am. J. Physiol. Heart Circ. Physiol. 292, H1561\u20131567 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2016118_CR104","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jacc.2007.03.041","volume":"50","author":"O Adam","year":"2007","unstructured":"Adam, O.  et al. Role of Rac1 GTPase activation in atrial fibrillation. J. Am. Coll. Cardiol. 50, 359\u2013367 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR105","doi-asserted-by":"publisher","first-page":"H386","DOI":"10.1152\/ajpheart.00004.2012","volume":"303","author":"A Scridon","year":"2012","unstructured":"Scridon, A.  et al. Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am. J. Physiol. Heart Circ. Physiol. 303, H386\u2013H392 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2016118_CR106","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/europace\/euu139","volume":"17","author":"A Scridon","year":"2015","unstructured":"Scridon, A.  et al. Long-standing arterial hypertension is associated with Pitx2 down-regulation in a rat model of spontaneous atrial tachyarrhythmias. Europace 17, 160\u2013165 (2015).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR107","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/CIRCULATIONAHA.110.972778","volume":"123","author":"K Nishida","year":"2011","unstructured":"Nishida, K.  et al. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model. Circulation 123, 137\u2013146 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR108","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/CIRCEP.107.754788","volume":"1","author":"Y-H Yeh","year":"2008","unstructured":"Yeh, Y.-H.  et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ. Arrhythm. Electrophysiol. 1, 93\u2013102 (2008).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2016118_CR109","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCRESAHA.108.183400","volume":"105","author":"B Burstein","year":"2009","unstructured":"Burstein, B.  et al. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ. Res. 105, 1213\u20131222 (2009).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR110","first-page":"A17762","volume":"122","author":"R Wakili","year":"2010","unstructured":"Wakili, R.  et al. Temporal evolution of atrial remodeling and atrial arrhythmogenesis during tachycardiomyopathic heart failure development. Circulation 122, A17762 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR111","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.108.776203","volume":"118","author":"AY Tan","year":"2008","unstructured":"Tan, A. Y.  et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation 118, 916\u2013925 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR112","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1161\/CIRCULATIONAHA.109.919829","volume":"121","author":"E-K Choi","year":"2010","unstructured":"Choi, E.-K.  et al. Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs. Circulation 121, 2615\u20132623 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR113","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jacc.2003.09.030","volume":"43","author":"OF Sharifov","year":"2004","unstructured":"Sharifov, O. F.  et al. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J. Am. Coll. Cardiol. 43, 483\u2013490 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR114","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/jce.12824","volume":"26","author":"JS Carneiro","year":"2015","unstructured":"Carneiro, J. S.  et al. The selective cardiac late sodium current inhibitor GS-458967 suppresses autonomically triggered atrial fibrillation in an intact porcine model. J. Cardiovasc. Electrophysiol. 26, 1364\u20131369 (2015).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR115","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cardiores.2005.02.011","volume":"66","author":"S Zicha","year":"2005","unstructured":"Zicha, S., Fern\u00e1ndez-Velasco, M., Lonardo, G., L'Heureux, N. & Nattel, S. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc. Res. 66, 472\u2013481 (2005).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR116","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/CIRCRESAHA.116.305326","volume":"116","author":"X-Y Qi","year":"2015","unstructured":"Qi, X.-Y.  et al. Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling. Circ. Res. 116, 836\u2013845 (2015).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR117","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.bpj.2014.10.014","volume":"107","author":"M Aguilar","year":"2014","unstructured":"Aguilar, M., Qi, X. Y., Huang, H., Comtois, P. & Nattel, S. Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation. Biophys. J. 107, 2444\u20132455 (2014).","journal-title":"Biophys. J."},{"key":"BFnrcardio2016118_CR118","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.112.121830","volume":"126","author":"M Harada","year":"2012","unstructured":"Harada, M.  et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 126, 2051\u20132064 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR119","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1113\/jphysiol.2013.261198","volume":"591","author":"N Jost","year":"2013","unstructured":"Jost, N.  et al. Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. J. Physiol. 591, 4189\u20134206 (2013).","journal-title":"J. Physiol."},{"key":"BFnrcardio2016118_CR120","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ahj.2012.02.015","volume":"163","author":"CB De Vos","year":"2012","unstructured":"De Vos, C. B.  et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. Am. Heart J. 163, 887\u2013893 (2012).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2016118_CR121","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","volume":"55","author":"CB de Vos","year":"2010","unstructured":"de Vos, C. B.  et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J. Am. Coll. Cardiol. 55, 725\u2013731 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR122","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","volume":"92","author":"MC Wijffels","year":"1995","unstructured":"Wijffels, M. C., Kirchhof, C. J., Dorland, R. & Allessie, M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92, 1954\u20131968 (1995).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR123","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.81.4.512","volume":"81","author":"L Yue","year":"1997","unstructured":"Yue, L.  et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 81, 512\u2013525 (1997).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR124","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCRESAHA.108.175463","volume":"103","author":"XY Qi","year":"2008","unstructured":"Qi, X. Y.  et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ. Res. 103, 845\u2013854 (2008).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR125","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1172\/JCI62185","volume":"123","author":"X Luo","year":"2013","unstructured":"Luo, X.  et al. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest. 123, 1939\u20131951 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2016118_CR126","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/CIRCRESAHA.114.301798","volume":"114","author":"M Harada","year":"2014","unstructured":"Harada, M.  et al. MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential. Circ. Res. 114, 689\u2013705 (2014).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR127","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1161\/01.CIR.96.9.3157","volume":"96","author":"J Ausma","year":"1997","unstructured":"Ausma, J.  et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96, 3157\u20133163 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR128","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.hrthm.2014.10.027","volume":"12","author":"S Kirubakaran","year":"2015","unstructured":"Kirubakaran, S.  et al. Fractionation of electrograms is caused by colocalized conduction block and connexin disorganization in the absence of fibrosis as AF becomes persistent in the goat model. Heart Rhythm 12, 397\u2013408 (2015).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2016118_CR129","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/CIRCEP.112.975144","volume":"6","author":"S Verheule","year":"2013","unstructured":"Verheule, S.  et al. Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ. Arrhythm. Electrophysiol. 6, 202\u2013211 (2013).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2016118_CR130","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cardiores.2007.07.013","volume":"76","author":"B Burstein","year":"2007","unstructured":"Burstein, B., Qi, X.-Y., Yeh, Y.-H., Calderone, A. & Nattel, S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc. Res. 76, 442\u2013452 (2007).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR131","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1540-8167.1999.tb00283.x","volume":"10","author":"CJ Garratt","year":"1999","unstructured":"Garratt, C. J.  et al. Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or stability of atrial fibrillation. J. Cardiovasc. Electrophysiol. 10, 1101\u20131108 (1999).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2016118_CR132","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1161\/01.CIR.0000124006.84596.D9","volume":"109","author":"DM Todd","year":"2004","unstructured":"Todd, D. M.  et al. Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation 109, 1434\u20131439 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR133","unstructured":"Wu, C.-T.  et al. Repeated paroxysmal atrial fibrillation episodes remodel ionic currents and promote atrial fibrillation in dogs. Circulation 128, [abstract 13765] (2013)."},{"key":"BFnrcardio2016118_CR134","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/europace\/eut232","volume":"15","author":"P Kirchhof","year":"2013","unstructured":"Kirchhof, P.  et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork\/European Heart Rhythm Association consensus conference. Europace 15, 1540\u20131556 (2013).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR135","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/FJC.0000000000000293","volume":"67","author":"JK Donahue","year":"2016","unstructured":"Donahue, J. K. Biological therapies for atrial fibrillation: ready for prime time? J. Cardiovasc. Pharmacol. 67, 19\u201325 (2016).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnrcardio2016118_CR136","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2014.06.1172","volume":"64","author":"K Nishida","year":"2014","unstructured":"Nishida, K., Datino, T., Macle, L. & Nattel, S. Atrial fibrillation ablation: translating basic mechanistic insights to the patient. J. Am. Coll. Cardiol. 64, 823\u2013831 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016118_CR137","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.109.893107","volume":"121","author":"T Datino","year":"2010","unstructured":"Datino, T.  et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins. Circulation 121, 963\u2013972 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio2016118_CR138","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","volume":"114","author":"P-S Chen","year":"2014","unstructured":"Chen, P.-S., Chen, L. S., Fishbein, M. C., Lin, S.-F. & Nattel, S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ. Res. 114, 1500\u20131515 (2014).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR139","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/europace\/euv263","volume":"18","author":"SJ Podd","year":"2016","unstructured":"Podd, S. J., Freemantle, N., Furniss, S. S. & Sulke, N. First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation. Europace 18, 340\u2013346 (2016).","journal-title":"Europace"},{"key":"BFnrcardio2016118_CR140","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/cvr\/cvv275","volume":"109","author":"J Heijman","year":"2016","unstructured":"Heijman, J.  et al. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. Cardiovasc. Res. 109, 467\u2013479 (2016).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016118_CR141","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cjca.2014.10.027","volume":"31","author":"RK Pathak","year":"2015","unstructured":"Pathak, R. K., Mahajan, R., Lau, D. H. & Sanders, P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can. J. Cardiol. 31, 203\u2013210 (2015).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio2016118_CR142","doi-asserted-by":"publisher","unstructured":"Gal, P. & Marrouche, N. F. Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome. Eur. Heart J. \n                    http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehv514\n                    \n                   (2015).","DOI":"10.1093\/eurheartj\/ehv514"},{"key":"BFnrcardio2016118_CR143","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCRESAHA.112.279315","volume":"112","author":"Y Rudy","year":"2013","unstructured":"Rudy, Y. Noninvasive electrocardiographic imaging of arrhythmogenic substrates in humans. Circ. Res. 112, 863\u2013874 (2013).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016118_CR144","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","volume":"373","author":"T Watson","year":"2009","unstructured":"Watson, T., Shantsila, E. & Lip, G. Y. H. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 373, 155\u2013166 (2009).","journal-title":"Lancet"},{"key":"BFnrcardio2016118_CR145","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/415219a","volume":"415","author":"S Nattel","year":"2002","unstructured":"Nattel, S. New ideas about atrial fibrillation 50 years on. Nature 415, 219\u2013226 (2002).","journal-title":"Nature"},{"key":"BFnrcardio2016118_CR146","doi-asserted-by":"publisher","first-page":"H2017","DOI":"10.1152\/ajpheart.00537.2008","volume":"295","author":"S Mancarella","year":"2008","unstructured":"Mancarella, S.  et al. Impaired Ca2+ homeostasis is associated with atrial fibrillation in the \u03b11D L-type Ca2+ channel KO mouse. Am. J. Physiol. Heart Circ. Physiol. 295, H2017\u2013H2024 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:57:44Z","timestamp":1684468664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2016.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":146,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnrcardio2016118"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2016.118","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]},"assertion":[{"value":"4 August 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.D. declares that he has received consultancy fees and research grants from OMEICOS Therapeutics GmbH and Xention. S.N. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}